Literature DB >> 27067626

Unbiased identification of substrates of protein tyrosine phosphatase ptp-3 in C. elegans.

Christopher J Mitchell1, Min-Sik Kim1, Jun Zhong1, Raja Sekhar Nirujogi2, Anjun K Bose1, Akhilesh Pandey3.   

Abstract

The leukocyte antigen related (LAR) family of receptor-like protein tyrosine phosphatases has three members in humans - PTPRF, PTPRD and PTPRS - that have been implicated in diverse processes including embryonic development, inhibition of cell growth and axonal guidance. Mutations in the LAR family are associated with developmental defects such as cleft palate as well as various cancers including breast, neck, lung, colon and brain. Although this family of tyrosine phosphatases is important for many developmental processes, little is known of their substrates. This is partially due to functional redundancy within the LAR family, as deletion of a single gene in the LAR family does not have an appreciable phenotype, but a dual knockout is embryonically lethal in mouse models. To circumvent the inability to knockout multiple members of the LAR family in mouse models, we used a knockout of ptp-3, which is the only known ortholog of the LAR family in Caenorhabditis elegans and allows for the study of the LAR family at the organismal level. Using SILAC-based quantitative phosphoproteomics, we identified 255 putative substrates of ptp-3, which included four of the nine known annotated substrates of the LAR family. A motif analysis of the identified phosphopeptides allowed for the determination of sequences that appear to be preferentially dephosphorylated. Finally, we discovered that kinases were overrepresented in the list of identified putative substrates and tyrosine residues whose phosphorylation is known to increase kinase activity were dephosphorylated by ptp-3. These data are suggestive of ptp-3 as a potential negative regulator of several kinase families, such as the mitogen activated kinases (MAPKs), and multiple tyrosine kinases including FER, MET, and NTRK2.
Copyright © 2016 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Phosphoproteomics; Protein tyrosine phosphatases; Tyrosine phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27067626      PMCID: PMC5423164          DOI: 10.1016/j.molonc.2016.03.003

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  52 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.

Authors:  John Rush; Albrecht Moritz; Kimberly A Lee; Ailan Guo; Valerie L Goss; Erik J Spek; Hui Zhang; Xiang-Ming Zha; Roberto D Polakiewicz; Michael J Comb
Journal:  Nat Biotechnol       Date:  2004-12-12       Impact factor: 54.908

3.  Full activation of the platelet-derived growth factor beta-receptor kinase involves multiple events.

Authors:  R M Baxter; J P Secrist; R R Vaillancourt; A Kazlauskas
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

4.  The divergent C. elegans ephrin EFN-4 functions inembryonic morphogenesis in a pathway independent of the VAB-1 Eph receptor.

Authors:  Ian D Chin-Sang; Sarah L Moseley; Mei Ding; Robert J Harrington; Sean E George; Andrew D Chisholm
Journal:  Development       Date:  2002-12       Impact factor: 6.868

5.  Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44.

Authors:  Kosuke Funato; Yusuke Yamazumi; Takeaki Oda; Tetsu Akiyama
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

6.  High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.

Authors:  Maciej Giefing; Natalia Zemke; Damian Brauze; Magdalena Kostrzewska-Poczekaj; Magdalena Luczak; Marcin Szaumkessel; Kinga Pelinska; Katarzyna Kiwerska; Holger Tönnies; Reidar Grenman; Marek Figlerowicz; Reiner Siebert; Krzysztof Szyfter; Malgorzata Jarmuz
Journal:  Genes Chromosomes Cancer       Date:  2010-12-07       Impact factor: 5.006

7.  The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.

Authors:  Selvaraju Veeriah; Cameron Brennan; Shasha Meng; Bhuvanesh Singh; James A Fagin; David B Solit; Philip B Paty; Dan Rohle; Igor Vivanco; Juliann Chmielecki; William Pao; Marc Ladanyi; William L Gerald; Linda Liau; Timothy C Cloughesy; Paul S Mischel; Chris Sander; Barry Taylor; Nikolaus Schultz; John Major; Adriana Heguy; Fang Fang; Ingo K Mellinghoff; Timothy A Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-28       Impact factor: 11.205

8.  Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.

Authors:  Min-Sik Kim; Yi Zhong; Shinichi Yachida; N V Rajeshkumar; Melissa L Abel; Arivusudar Marimuthu; Keshav Mudgal; Ralph H Hruban; Justin S Poling; Jeffrey W Tyner; Anirban Maitra; Christine A Iacobuzio-Donahue; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2014-06-03       Impact factor: 5.911

9.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations.

Authors:  Peter V Hornbeck; Bin Zhang; Beth Murray; Jon M Kornhauser; Vaughan Latham; Elzbieta Skrzypek
Journal:  Nucleic Acids Res       Date:  2014-12-16       Impact factor: 16.971

10.  Discovering sequence motifs with arbitrary insertions and deletions.

Authors:  Martin C Frith; Neil F W Saunders; Bostjan Kobe; Timothy L Bailey
Journal:  PLoS Comput Biol       Date:  2008-05-09       Impact factor: 4.475

View more
  7 in total

1.  Spatial confinement of receptor activity by tyrosine phosphatase during directional cell migration.

Authors:  Zhiwen Zhu; Yongping Chai; Huifang Hu; Wei Li; Wen-Jun Li; Meng-Qiu Dong; Jia-Wei Wu; Zhi-Xin Wang; Guangshuo Ou
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

Review 2.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

3.  Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.

Authors:  George R Uhl; Maria J Martinez; Paul Paik; Agnieszka Sulima; Guo-Hua Bi; Malliga R Iyer; Eliot Gardner; Kenner C Rice; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

Review 4.  MET targeting: time for a rematch.

Authors:  Jonas P Koch; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

Review 5.  LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain.

Authors:  Francisca Cornejo; Bastián I Cortés; Greg M Findlay; Gonzalo I Cancino
Journal:  Front Cell Dev Biol       Date:  2021-12-13

6.  l-Lactate Dehydrogenase Identified as a Protein Tyrosine Phosphatase 1B Substrate by Using K-BIPS.

Authors:  Nuwan P N Acharige; Mary Kay H Pflum
Journal:  Chembiochem       Date:  2020-12-07       Impact factor: 3.164

7.  PTP-3 phosphatase promotes intramolecular folding of SYD-2 to inactivate kinesin-3 UNC-104 in neurons.

Authors:  Muthaiyan Shanmugam Muniesh; Syed Nooruzuha Barmaver; Hsin-Yi Huang; Odvogmed Bayansan; Oliver Ingvar Wagner
Journal:  Mol Biol Cell       Date:  2020-11-04       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.